Radiation Oncologist and Co-Director of the Genitourinary Program, Shalini Moningi, MD, joins the Cancer Advances podcast to discuss the latest advances in radiation therapy for prostate cancer. Listen as Dr. Moningi talks about SBRT, adaptive radiation, emerging biomarker data, and how these innovations are reshaping treatment selection, toxicity profiles, and patient's quality of life.

Breast density affects 50% of women and can significantly impact both cancer risk and early detection. Breast Radiologist, Paulette Turk, MD, and Medical Breast Program Director, Lakshmi Khatri, MD, join the Cancer Advances Podcast to discuss breast density, its risk implications and the role of supplemental screening. Listen as they explain how Cleveland Clinic is defining practical screening pathways in an area where national guidelines continue to evolve.

Shahzad Raza, MD, Hematologist at Cleveland Clinic, joins the Cancer Advances podcast to share insights from the RedirecTT-1 study. This study, presented at the 2025 American Society of Hematology (ASH) Annual Meeting, explores combining two bispecific antibodies, talquetamab and teclistamab, for patients with relapsed/refractory multiple myeloma with extramedullary disease. Listen as Dr. Raza discusses disease biology, outcomes, safety considerations and why this approach could be a major step forward for high-risk myeloma care.

Certified Oncology Social Worker Jane Dabney, MSW, LISW-S, OSW-C, joins the Cancer Advances Podcast to talk about the vital role social workers play in blood cancer care. Listen as she explains how social work helps identify barriers to transplant and cellular therapy, supports patient and caregiver preparedness, and strengthens continuity of care.

Urologic Oncologist at Cleveland Clinic Weston Hospital, Alberto Pieretti, MD, joins the Cancer Advances Podcast to talk about how innovations in imaging, biomarkers and multidisciplinary care are reshaping the diagnosis and management of prostate cancer. Hear how advances such as PSMA PET scans, biomarker-guided biopsies and precision therapies are improving outcomes and quality of life for patients.

Joseph Skitzki, MD, Director of Melanoma and Cutaneous Oncology Surgery at Cleveland Clinic, joins the Cancer Advances podcast to discuss how neoadjuvant immunotherapy is transforming melanoma treatment. Listen as Dr. Skitzki explains how this approach is improving survival and reducing the need for extensive surgery.

Allison Winter, MD, Hematology Oncologist and Medical Director for VeloSano, returns to the Cancer Advances podcast to discuss the latest advances in diagnosing and managing primary CNS lymphoma. Listen as Dr. Winter shares how evolving treatment strategies, including CAR T-cell therapy and novel clinical trials, are improving outcomes and helping preserve cognitive function.

Pregnancy-associated breast cancer is rare and complex, requiring careful coordination across specialties. Erin Roesch, MD, Breast Medical Oncologist, joins the Cancer Advances Podcast to discuss how a multidisciplinary team approach helps optimize treatment timing, ensures maternal and fetal safety, and supports patients through diagnosis, therapy, and recovery.